DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Synergistic Combination of Antimicrobial Peptides and Cationic Polyitaconates in Multifunctional PLA Fibers
Combining different antimicrobial agents has emerged as a promising strategy to enhance efficacy and address resistance evolution. In this study, we investigated the synergistic antimicrobial effect of a cationic biobased polymer and the antimicrobial peptide (AMP) temporin L, with the goal of developing multifunctional electrospun fibers for potential biomedical applications, particularly in wound dressing. A clickable polymer with pendent alkyne groups was synthesized by using a biobased itaconic acid building block. Subsequently, the polymer was functionalized through click chemistry with thiazolium groups derived from vitamin B1 (PTTIQ), as well as a combination of thiazolium and AMP temporin L, resulting in a conjugate polymer-peptide (PTTIQ-AMP). The individual and combined effects of the cationic PTTIQ, Temporin L, and PTTIQ-AMP were evaluated against Gram-positive and Gram-negative bacteria as well as Candida species. The results demonstrated that most combinations exhibited an indifferent effect, whereas the covalently conjugated PTTIQ-AMP displayed an antagonistic effect, potentially attributed to the aggregation process. Both antimicrobial compounds, PTTIQ and temporin L, were incorporated into poly(lactic acid) electrospun fibers using the supercritical solvent impregnation method. This approach yielded fibers with improved antibacterial performance, as a result of the potent activity exerted by the AMP and the nonleaching nature of the cationic polymer, thereby enhancing long-term effectiveness., This work was funded by the MICINN (PID2019-104600RB-
I00 and PID2021-123553OA-I00), the Agencia Estatal de
Investigación (AEI, Spain), and Fondo Europeo de Desarrollo
Regional (FEDER, EU) and by CSIC (LINKA20364). A.
Chiloeches acknowledges MICIU for his FPU fellowship
FPU18/01776. Cesar de la Fuente-Nunez holds a Presidential
Professorship at the University of Pennsylvania and acknowl-
edges funding from the Procter & Gamble Company, United
Therapeutics, a BBRF Young Investigator Grant, the Nemirovsky Prize, Penn Health-Tech Accelerator Award, and
the Dean’s Innovation Fund from the Perelman School of
Medicine at the University of Pennsylvania. Research reported
in this publication was supported by the Langer Prize (AIChE
Foundation), the National Institute of General Medical
Sciences of the National Institutes of Health under award
number R35GM138201, and the Defense Threat Reduction
Agency (DTRA; HDTRA11810041, HDTRA1-21-1-0014, and
HDTRA1-23-1-0001). D. Placha and J. Zagora acknowledge
the Doctoral grant competition VSB-Technical University of
Ostrava (reg. no. CZ.02.2.69/0.0/0.0/19_073/0016945) with-
in the Operational Programme Research, Development and
Education, under project DGS/INDIVIDUAL/2020-001
“Development of antimicrobial biobased polymeric material
using supercritical fluid technology”., Peer reviewed